NM
Neumora Therapeutics, Inc. Common Stock (NMRA)
NASDAQ·Healthcare·Biotechnology
$0.51
+0.29%
Mkt Cap $106.35M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (14 analysts)
$4.50
Range $4.00 – $5.00
Implied Upside
+788.5%
Consensus $4.50 vs current $0.51